Wearable watches track healthy movement for two years
NCT ID NCT07136506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is recruiting 200 healthy volunteers of all ages to wear a device called Syde, which looks like a watch, for three-week periods every six months over two years. The device records movement data like walking patterns and arm motion. The goal is to create a reference dataset of normal movement, which may help researchers better understand and monitor conditions that affect movement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Syde wearable device
- What this could lead to
- If successful, this study will provide a baseline of normal movement patterns, which could help improve diagnosis and monitoring of movement disorders in the future.
- What could go wrong
- This is an observational study with no treatment involved, so it will not directly benefit participants. The device may not be worn consistently, and results may not apply to people with health conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre de référence des maladies neuromusculaire, Centre Hospitalier Régional de la Citadelle
RECRUITINGLiège, 4000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates